{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:07:47Z","timestamp":1792804067429,"version":"4.5.0"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117801","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:24:34Z","timestamp":1747999474000},"page":"117801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Recent research frontiers of heterocycles as antifungal Agents: Insights from the past five years"],"prefix":"10.1016","volume":"295","author":[{"given":"Sumit","family":"Tahlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucheta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrithik","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Kaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash C.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117801_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/pathogens12020293","article-title":"Addressing microbial resistance worldwide: challenges over controlling life-threatening fungal infections","volume":"12","author":"Martins-Santana","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2025.117801_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.FUNK-0014-2016","article-title":"Fungi that infect humans","volume":"5","author":"Kohler","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2025.117801_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/jof9030381","article-title":"Clinical manifestations of human exposure to fungi","volume":"9","author":"Oliveira","year":"2023","journal-title":"J. Fungi"},{"key":"10.1016\/j.ejmech.2025.117801_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1292625","article-title":"Modulatory immune responses in fungal infection associated with organ transplant-advancements, management, and challenges","volume":"14","author":"Elalouf","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117801_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14787210.2020.1750368","article-title":"Multidrug-resistant Candida auris: an epidemiological review","volume":"18","author":"Chakrabarti","year":"2020","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2025.117801_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/microorganisms9040807","article-title":"Candida auris: epidemiology, diagnosis, pathogenesis, antifungal susceptibility, and infection control measures to combat the spread of infections in healthcare facilities","volume":"9","author":"Ahmad","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejmech.2025.117801_bib7","series-title":"Human Fungal Pathogen Identification: Methods and Protocols","first-page":"17","article-title":"The changing epidemiology of invasive fungal infections","author":"Enoch","year":"2017"},{"key":"10.1016\/j.ejmech.2025.117801_bib8","article-title":"Candida bloodstream infections: changes in epidemiology and increase in drug resistance","volume":"14","author":"Kotey","year":"2021","journal-title":"Infect. Dis. Res. Treat."},{"key":"10.1016\/j.ejmech.2025.117801_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.832510","article-title":"Recent advances in fungal infections: from lung ecology to therapeutic strategies with a focus on Aspergillus spp","volume":"9","author":"Palmieri","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2025.117801_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/1040841X.2022.2052795","article-title":"The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19","volume":"49","author":"Dwivedi","year":"2022","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117801_bib11","article-title":"New insights on mucormycosis and its association with the COVID-19 pandemic","volume":"8","author":"Alshahawey","year":"2021","journal-title":"Future Sci. OA."},{"key":"10.1016\/j.ejmech.2025.117801_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jointm.2024.01.005","article-title":"Fungal infections in immunocompromised critically ill patients","author":"Garnacho-Montero","year":"2024","journal-title":"J. Intensive Med."},{"key":"10.1016\/j.ejmech.2025.117801_bib13","first-page":"395","article-title":"Invasive fungal infections among immunocompromised patients in critical care settings: infection prevention risk mitigation","volume":"33","author":"Riley","year":"2021","journal-title":"Crit. Care Nurs. Clin."},{"key":"10.1016\/j.ejmech.2025.117801_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/jof9020171","article-title":"Sources of antifungal drugs","volume":"9","author":"Vanreppelen","year":"2023","journal-title":"J. Fungi"},{"key":"10.1016\/j.ejmech.2025.117801_bib15","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3390\/pharmaceutics13111961","article-title":"The overview on the pharmacokinetic and pharmacodynamic interactions of triazoles","volume":"13","author":"Czyrski","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.117801_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.892","article-title":"Real clinical impact of drug\u2013drug interactions of immunosuppressants in transplant patients","volume":"9","author":"Gago\u2010S\u00e1nchez","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejmech.2025.117801_bib17","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3390\/antibiotics11101381","article-title":"Individual pharmacotherapy management (IPM)\u2014IV: optimized usage of approved antimicrobials addressing under-recognized adverse drug reactions and drug\u2013drug interactions in polypharmacy","volume":"11","author":"Wolf","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2025.117801_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/apm.13336","article-title":"Azole resistance in Candida auris: mechanisms and combinatorial therapy","volume":"131","author":"Jangir","year":"2023","journal-title":"APMIS"},{"key":"10.1016\/j.ejmech.2025.117801_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jof7010024","article-title":"Antifungal resistance among less prevalent Candida non-albicans and other yeasts versus established and under development agents: a literature review","volume":"7","author":"Espinel-Ingroff","year":"2021","journal-title":"J. Fungi"},{"key":"10.1016\/j.ejmech.2025.117801_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02539-20","article-title":"Aspergillus fumigatus cross-resistance between clinical and demethylase inhibitor azole drugs","volume":"87","author":"Garcia-Rubio","year":"2021","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117801_bib21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/14740338.2021.1922667","article-title":"Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions","volume":"20","author":"Tragiannidis","year":"2021","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2025.117801_bib22","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1021\/acs.molpharmaceut.4c00485","article-title":"Formulation strategies to overcome amphotericin B induced toxicity","volume":"21","author":"Dash","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2025.117801_bib23","doi-asserted-by":"crossref","first-page":"ii11","DOI":"10.1093\/jac\/dkac352","article-title":"Liposomal amphotericin B\u2014The present","volume":"77","author":"Maertens","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.117801_bib24","doi-asserted-by":"crossref","first-page":"ii21","DOI":"10.1093\/jac\/dkac353","article-title":"Liposomal amphotericin B\u2014The future","volume":"77","author":"Hoenigl","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.117801_bib25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/antibiotics12050884","article-title":"Antifungals: from pharmacokinetics to clinical practice","volume":"12","author":"Carmo","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2025.117801_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/14656566.2024.2331775","article-title":"An evaluation of rezafungin: the latest treatment option for adults with candidemia and invasive candidiasis","volume":"25","author":"Sharma","year":"2024","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117801_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00074-23","article-title":"Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease","volume":"37","author":"Hoenigl","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2025.117801_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200221","article-title":"SAR analysis of heterocyclic compounds with monocyclic and bicyclic structures as antifungal agents","volume":"17","author":"Yang","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117801_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/cbdd.14266","article-title":"Recent advances in antifungal drug development targeting lanosterol 14\u03b1\u2010demethylase (CYP51): a comprehensive review with structural and molecular insights","volume":"102","author":"Singh","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.117801_bib30","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1021\/acs.jmedchem.3c00942","article-title":"Design, synthesis, and activity evaluation of novel dual-target inhibitors with antifungal and immunoregulatory properties","volume":"66","author":"Sun","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib31","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1021\/acs.jmedchem.0c00102","article-title":"Discovery of novel fungal lanosterol 14\u03b1-demethylase (CYP51)\/histone deacetylase dual inhibitors to treat azole-resistant candidiasis","volume":"63","author":"Han","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib32","article-title":"Lanosterol 14\u03b1-demethylase (CYP51)\/heat shock protein 90 (Hsp90) dual inhibitors for the treatment of invasive candidiasis","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00253-020-11022-y","article-title":"Echinocandins: structural diversity, biosynthesis, and development of antimycotics","volume":"105","author":"H\u00fcttel","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.117801_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myae032","article-title":"Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598","volume":"62","author":"Gu","year":"2024","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ejmech.2025.117801_bib35","first-page":"1","article-title":"Review of the novel antifungal drug olorofim (F901318)","volume":"24","author":"Vanbiervliet","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117801_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103206","article-title":"Ebselen improves fungal keratitis through exerting anti-inflammation, anti-oxidative stress, and antifungal effects","volume":"73","author":"Yu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2025.117801_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.126951","article-title":"Design, synthesis, and structure\u2013activity relationship studies of novel triazole agents with strong antifungal activity against Aspergillus fumigatus","volume":"30","author":"Ding","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117801_bib38","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.3390\/ijms22136979","article-title":"Antimicrobial activity of 1,3,4-oxadiazole derivatives","volume":"22","author":"Glomb","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117801_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115658","article-title":"Strategies of targeting CYP51 for IFIs therapy: emerging prospects, opportunities and challenges","volume":"259","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116942","article-title":"Identification of novel and potent triazoles targeting CYP51 for antifungal: design, synthesis, and biological study","volume":"280","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib41","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/molecules22112004","article-title":"Synthesis of oxadiazole-thiadiazole hybrids and their anticandidal activity","volume":"22","author":"Levent","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib42","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1128\/AAC.00477-12","article-title":"Amino acid-derived 1,2-benzisothiazolinone derivatives as novel small-molecule antifungal inhibitors: identification of potential genetic targets","volume":"56","author":"Alex","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117801_bib43","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3390\/ijms23052756","article-title":"Emerging antifungal targets and strategies","volume":"23","author":"Ivanov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117801_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2018.10.008","article-title":"Antifungal drugs: new insights in research & development","volume":"195","author":"Nicola","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.117801_bib45","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/jpm11090926","article-title":"A systematic review on the contribution of artificial intelligence in the development of medicines for COVID-2019","volume":"11","author":"Pires","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.ejmech.2025.117801_bib46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.coph.2009.08.004","article-title":"Novel trends in high-throughput screening","volume":"9","author":"Mayr","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117801_bib47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/ph13090248","article-title":"Current insights on antifungal therapy: novel nanotechnology approaches for drug delivery systems and new drugs from natural sources","volume":"13","author":"Sousa","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117801_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70045","article-title":"The significance of mono\u2010 and dual\u2010effective agents in the development of new antifungal strategies","volume":"105","author":"Zobi","year":"2025","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.117801_bib49","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.3390\/app11157119","article-title":"Nanoarchitectures in management of fungal diseases: an overview","volume":"11","author":"Mishra","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejmech.2025.117801_bib50","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jobm.202100204","article-title":"Potent antifungal agents and use of nanocarriers to improve delivery to the infected site: a systematic review","volume":"61","author":"Nagaraj","year":"2021","journal-title":"J. Basic Microbiol."},{"key":"10.1016\/j.ejmech.2025.117801_bib51","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2174\/1573407214666180717111419","article-title":"Chemistry and pharmacology of luliconazole (imidazole derivative): a novel bioactive compound to treat fungal infection\u2014a mini review","volume":"15","author":"Mishra","year":"2019","journal-title":"Curr. Bioact. Compd."},{"key":"10.1016\/j.ejmech.2025.117801_bib52","series-title":"Nanomedicines for the Prevention and Treatment of Infectious Diseases","first-page":"125","article-title":"Nanomedicine for the treatment of vaginal candidiasis","author":"Vartak","year":"2023"},{"key":"10.1016\/j.ejmech.2025.117801_bib53","series-title":"Recent Advances in Human Fungal Diseases: Progress and Prospects","first-page":"43","article-title":"Fungal fighters: a comprehensive guide to antifungal therapies of the past, present, and future","author":"Biswas","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117801_bib54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10482-023-01914-0","article-title":"Species distribution and antifungal susceptibility profiles of yeasts isolated from onychomycosis: a cross-sectional study with insights into emerging species","volume":"117","author":"Yazdanpanah","year":"2024","journal-title":"Antonie Leeuwenhoek"},{"key":"10.1016\/j.ejmech.2025.117801_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2021.102961","article-title":"Efficacy of topical isoconazole nitrate in the treatment of otomycosis","volume":"42","author":"G\u00fcl\u00fcstan","year":"2021","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.ejmech.2025.117801_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05031-22","article-title":"Oxiconazole potentiates gentamicin against gentamicin-resistant Staphylococcus aureus in vitro and in vivo","volume":"11","author":"Kaul","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2025.117801_bib57","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1007\/s00253-021-11477-7","article-title":"The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans","volume":"105","author":"Biernasiuk","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.117801_bib58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40360-025-00850-1","article-title":"In vivo toxicological evaluation of 3-benzylideneindolin-2-one: antifungal activity against clinical isolates of dermatophytes","volume":"26","author":"Rajakulasooriya","year":"2025","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117801_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38963-4","article-title":"Xanthone synthetic derivatives with high anticandidal activity and positive mycostatic selectivity index values","volume":"13","author":"Rz\u0105d","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117801_bib60","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s42770-022-00725-1","article-title":"A novel naphthoquinone derivative shows selective antifungal activity against Sporothrix yeasts and biofilms","volume":"53","author":"Borba-Santos","year":"2022","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117801_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127413","article-title":"Synthesis of novel lignan-like compounds and their antimicrobial activity","volume":"30","author":"Tufano","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117801_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12272-013-0262-8","article-title":"Synthesis, analgesic, anti-inflammatory and in vitro antimicrobial activities of some novel isoxazole coupled quinazolin-4(3H)-one derivatives","volume":"44","author":"Saravanan","year":"2021","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2025.117801_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42714-w","article-title":"Synthesis, spectroscopic, DFT calculations, biological activity, SAR, and molecular docking studies of novel bioactive pyridine derivatives","volume":"13","author":"Anwer","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117801_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128117","article-title":"Design, synthesis and antimicrobial activity of novel 2-aminothiophene containing cyclic and heterocyclic moieties","volume":"44","author":"Asiri","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117801_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000468","article-title":"Multitarget-directed therapeutics: (Urea\/thiourea)2 derivatives of diverse heterocyclic-Lys conjugates","volume":"354","author":"Pavan Kumar","year":"2021","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.117801_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/open.202400142","article-title":"Eco-friendly regioselective synthesis, biological evaluation of some new 5-acylfunctionalized 2-(1H-pyrazol-1-yl)thiazoles as potential antimicrobial and anthelmintic agents","volume":"13","author":"Aggarwal","year":"2024","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.ejmech.2025.117801_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202000100","article-title":"Antimicrobial pyridazines: synthesis, characterization, cytotoxicity, substrate promiscuity, and molecular docking","volume":"17","author":"Mustafa","year":"2020","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2025.117801_bib68","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/molecules30010076","article-title":"Antimicrobial activity and mode of action of N-heterocyclic carbene silver(I) complexes","volume":"30","author":"Castagliuolo","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib69","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.3390\/molecules29225384","article-title":"Synthesis and antimicrobial activity of 3-Alkylidene-2-Indolone derivatives","volume":"29","author":"Huang","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib70","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.3390\/molecules29215058","article-title":"Design, synthesis, molecular docking, and ADME-tox investigations of Imidazo[1,2-a]Pyrimidines derivatives as antimicrobial agents","volume":"29","author":"Benzenine","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib71","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.3390\/molecules29194778","article-title":"Design, synthesis, and antimicrobial evaluation of new thiopyrimidine-benzenesulfonamide compounds","volume":"29","author":"Khalifa","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib72","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.3390\/molecules29194655","article-title":"\u03b2-Cyclodextrin catalyzed, one-pot multicomponent synthesis and antimicrobial potential of N-Aminopolyhydroquinoline derivatives","volume":"29","author":"Garg","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib73","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.3390\/molecules29102319","article-title":"Synthesis, characterization and antimicrobial and anticancer evaluations of some novel heteroannulated Difuro[3,2-c:3',2'-g]Chromenes","volume":"29","author":"Alshaye","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib74","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1080\/14786419.2019.1648459","article-title":"Synthesis of new 1,3-thiazol derivatives of maleopimaric acid as anticancer, antibacterial and antifungal agents","volume":"35","author":"Sultanova","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2025.117801_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000208","article-title":"Synthesis and antimicrobial activity of new 2-piperazin-1-yl-N-1,3-thiazol-2-ylacetamides of cyclopenta[c]pyridines and pyrano[3,4-c]pyridines","volume":"354","author":"Sirakanyan","year":"2021","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.117801_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000164","article-title":"New N-phenylacetamide-linked 1,2,3-triazole-tethered coumarin conjugates: synthesis, bioevaluation, and molecular docking study","volume":"353","author":"Akolkar","year":"2020","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.117801_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900241","article-title":"Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds","volume":"353","author":"Trefzger","year":"2020","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.117801_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015120","article-title":"Design, synthesis, and biological evaluation of N'-phenylhydrazides as potential antifungal agents","volume":"24","author":"Zhu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117801_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104164","article-title":"Design, synthesis, antimicrobial activity and molecular docking studies of some novel di-substituted sulfonylquinoxaline derivatives","volume":"104","author":"Ammar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104509","article-title":"Synthesis, biological evaluation and QSAR studies of new thieno[2,3-d]pyrimidin-4(3H)-one derivatives as antimicrobial and antifungal agents","volume":"106","author":"Magoulas","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104611","article-title":"Synthesis, biological evaluation and molecular docking studies of novel quinazolinones as antitubercular and antimicrobial agents","volume":"108","author":"Kumar Pandey","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104803","article-title":"Novel structural hybrids of quinoline and thiazole moieties: synthesis and evaluation of antibacterial and antifungal activities with molecular modeling studies","volume":"110","author":"Eissa","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104841","article-title":"Design, synthesis and mechanistic study of new 1,2,4-triazole derivatives as antimicrobial agents","volume":"111","author":"Amin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105227","article-title":"Molecular modelling, synthesis and antimicrobial evaluation of benzimidazole nucleoside mimetics","volume":"115","author":"Chaurasia","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126869","article-title":"Design, synthesis and bio-evaluation of C-1 alkylated tetrahydro-\u03b2-carboline derivatives as novel antifungal lead compounds","volume":"30","author":"Singh","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117801_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.126951","article-title":"Design, synthesis, and structure-activity relationship studies of novel triazole agents with strong antifungal activity against Aspergillus fumigatus","volume":"30","author":"Ding","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117801_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128004","article-title":"Design and synthesis, biological evaluation of bis-(1,2,3- and 1,2,4)-triazole derivatives as potential antimicrobial and antifungal agents","volume":"41","author":"Bitla","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117801_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128196","article-title":"Anti-protozoal and anti-fungal evaluation of 3,5-disubstituted 1,2-dioxolanes","volume":"47","author":"Pinet","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117801_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127944","article-title":"Synthesis and antifungal activity of new hybrids thiazolo[4,5-d]pyrimidines with (1H-1,2,4)triazole","volume":"40","author":"Blokhina","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117801_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127434","article-title":"Novel isoniazid embedded triazole derivatives: synthesis, antitubercular and antimicrobial activity evaluation","volume":"30","author":"Patil","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117801_bib91","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1080\/14756366.2021.1984904","article-title":"Synthesis of novel pyrroles and fused pyrroles as antifungal and antibacterial agents","volume":"36","author":"Abd El-Hameed","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib92","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.3390\/molecules29235743","article-title":"Impact of alkyl spacer and side chain on antimicrobial activity of monocationic and dicationic imidazolium surface-active ionic liquids: experimental and theoretical insights","volume":"29","author":"Wojcieszak","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib93","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.3390\/molecules28176340","article-title":"Exploration of baicalein-core derivatives as potent antifungal agents: SAR and mechanism insights","volume":"28","author":"Zhou","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib94","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/molecules28031135","article-title":"Design, synthesis and structure-activity relationship studies of nicotinamide derivatives as potent antifungal agents by disrupting cell wall","volume":"28","author":"Ni","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib95","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.3390\/molecules27134015","article-title":"Regioselective one-pot synthesis, biological activity and molecular docking studies of novel conjugates N-(p-aryltriazolyl)-1,5-benzodiazepin-2-ones as potent antibacterial and antifungal agents","volume":"27","author":"Nsira","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib96","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.3390\/molecules27123886","article-title":"Novel \u03b1-aminophosphonates and \u03b1-aminophosphonic acids: synthesis, molecular docking and evaluation of antifungal activity against Scedosporium species","volume":"27","author":"Cordero-D\u00edaz","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib97","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/molecules27030582","article-title":"Antimicrobial activity and DFT studies of a novel set of spiropyrrolidines tethered with thiochroman-4-one\/chroman-4-one scaffolds","volume":"27","author":"Chouch\u00e8ne","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib98","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.3390\/molecules26185463","article-title":"The antifungal action mode of N-phenacyldibromobenzimidazoles","volume":"26","author":"Staniszewska","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib99","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.3390\/molecules26165008","article-title":"In vitro anti-candida activity and action mode of benzoxazole derivatives","volume":"26","author":"Staniszewska","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib100","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.3390\/molecules26144304","article-title":"Chromenol derivatives as novel antifungal agents: synthesis, in silico and in vitro evaluation","volume":"26","author":"Zveaghintseva","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib101","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/molecules25143188","article-title":"Design, facile synthesis and characterization of dichloro substituted chalcones and dihydropyrazole derivatives for their antifungal, antitubercular and antiproliferative activities","volume":"25","author":"Shaik","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105259","article-title":"Microwave prompted solvent-free synthesis of new series of heterocyclic tagged 7-arylidene indanone hybrids and their computational, antifungal, antioxidant, and cytotoxicity study","volume":"115","author":"Adole","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib103","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.3390\/molecules26237208","article-title":"Synthesis, biological evaluation, and structure-activity relationships of 4-aminopiperidines as novel antifungal agents targeting ergosterol biosynthesis","volume":"26","author":"Krau\u00df","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib104","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.3390\/molecules25245999","article-title":"Synthesis and influence of 3-amino benzoxaboroles structure on their activity against Candida albicans","volume":"25","author":"Wieczorek","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112082","article-title":"New azole antifungals with a fused triazinone scaffold","volume":"189","author":"Montoir","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107407","article-title":"1,3-Oxazole derivatives of cytisine as potential inhibitors of glutathione reductase of Candida spp.: QSAR modeling, docking analysis and experimental study of new anti-Candida agents","volume":"90","author":"Metelytsia","year":"2021","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2019.107189","article-title":"Indole-derived chalcones as anti-dermatophyte agents: in vitro evaluation and in silico study","volume":"84","author":"Mirzaei","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib108","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1021\/acs.jnatprod.0c00171","article-title":"Synthesis and antimicrobial activity of Burkholderia-related 4-hydroxy-3-methyl-2-alkenylquinolines (HMAQs) and their N-oxide counterparts","volume":"83","author":"Piochon","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.117801_bib109","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1021\/acs.jnatprod.1c00116","article-title":"Synthesis and antifungal activity evaluation of phloeodictine analogues","volume":"84","author":"Ravu","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2025.117801_bib110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cmdc.202000312","article-title":"The triazole ring as a privileged scaffold for putative antifungals: synthesis and evaluation of a series of new analogues","volume":"16","author":"Zoidis","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117801_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202100714","article-title":"Design, synthesis, in vitro and in silico characterization of 2-quinolone-L-alaninate-1,2,3-triazoles as antimicrobial agents","volume":"17","author":"Moussaoui","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117801_bib112","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.2147\/DDDT.S270896","article-title":"Synthesis, cytotoxic analysis, and molecular docking studies of tetrazole derivatives via N-Mannich base condensation as potential antimicrobials","volume":"14","author":"Atef Hatamleh","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2025.117801_bib113","doi-asserted-by":"crossref","first-page":"ftac013","DOI":"10.1093\/femspd\/ftac013","article-title":"Discovery of spirooxindole-pyrrolidine heterocyclic hybrids with potent antifungal activity against fungal pathogens","volume":"80","author":"Dowdy","year":"2022","journal-title":"Pathog Dis"},{"key":"10.1016\/j.ejmech.2025.117801_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138186","article-title":"Novel pyrazole derivatives: rationale design, synthesis, SAR study and biological potential based on in vitro study","volume":"1310","author":"Singh","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117801_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140169","article-title":"Design, synthesis, and biological evaluation of novel bis-pyrazole derivatives: a unified in silico and experimental methodology","volume":"1321","author":"Singh","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117801_bib116","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3390\/molecules27041246","article-title":"Synthesis and antimicrobial, anticancer and antioxidant activities of novel 2,3-dihydropyrido[2,3-d]pyrimidine-4-one and pyrrolo[2,1-b][1,3]benzothiazole derivatives via microwave-assisted synthesis","volume":"27","author":"Al-Mutairi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib117","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/molecules27030803","article-title":"Novel pyridothienopyrimidine derivatives: design, synthesis and biological evaluation as antimicrobial and anticancer agents","volume":"27","author":"Mohi El-Deen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib118","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/molecules27010074","article-title":"Synthesis of novel thiazole derivatives bearing \u03b2-amino acid and aromatic moieties as promising scaffolds for the development of new antibacterial and antifungal candidates targeting multidrug-resistant pathogens","volume":"27","author":"Mal\u016bkait\u0117","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib119","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.3390\/molecules26082292","article-title":"Design, synthesis, and antimicrobial activity of certain new indole-1,2,4-triazole conjugates","volume":"26","author":"Al-Wabli","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib120","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3390\/molecules25081964","article-title":"5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl)alkancarboxylic acids as antimicrobial agents: synthesis, biological evaluation, and molecular docking studies","volume":"25","author":"Horishny","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib121","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s11030-020-10125-y","article-title":"Ultrasound-assisted, low-solvent and acid\/base-free synthesis of 5-substituted 1,3,4-oxadiazole-2-thiols as potent antimicrobial and antioxidant agents","volume":"25","author":"Yarmohammadi","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2025.117801_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127368","article-title":"New vinyl-1,2,4-triazole derivatives as antimicrobial agents: synthesis, biological evaluation and molecular docking studies","volume":"30","author":"Stingaci","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117801_bib123","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.jiph.2020.09.017","article-title":"Antimicrobial activity of novel 5-benzylidene-3-(3-phenylallylideneamino)imidazolidine-2,4-dione derivatives causing clinical pathogens: synthesis and molecular docking studies","volume":"13","author":"Ali","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ejmech.2025.117801_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103908","article-title":"Novel pyranopyrazole derivatives comprising a benzoxazole core as antimicrobial inhibitors: design, synthesis, microbial resistance and machine-aided results","volume":"100","author":"Reddy","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib125","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3390\/medicina59061107","article-title":"Uridine derivatives: synthesis, biological evaluation, and in silico studies as antimicrobial and anticancer agents","volume":"59","author":"Munia","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ejmech.2025.117801_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112278","article-title":"Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinolinone derivatives as potential chitin synthase inhibitors and antifungal agents","volume":"195","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113048","article-title":"Design, synthesis, and biodistribution studies of new analogues of marine alkaloids: potent in vitro and in vivo fungicidal agents against Candida spp","volume":"210","author":"Andrade","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100287","article-title":"Green synthesis of novel antifungal 1,2,4-triazoles effective against \u03b3-irradiated Candida parapsilosis","volume":"355","author":"El-Hazek","year":"2022","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.117801_bib129","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1021\/acs.jmedchem.3c00942","article-title":"Design, synthesis, and activity evaluation of novel dual-target inhibitors with antifungal and immunoregulatory properties","volume":"66","author":"Sun","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1039\/C7NP00032D","article-title":"From genomics to metabolomics, moving toward an integrated strategy for the discovery of fungal secondary metabolites","volume":"35","author":"Hautbergue","year":"2018","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2025.117801_bib131","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fmicb.2017.00336","article-title":"Antifungal therapy for systemic mycosis and the nanobiotechnology era: improving efficacy, biodistribution and toxicity","volume":"8","author":"Souza","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117801_bib132","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3390\/ijms23052756","article-title":"Emerging antifungal targets and strategies","volume":"23","author":"Ivanov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117801_bib133","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3390\/jof10120871","article-title":"New ground in antifungal discovery and therapy for invasive fungal infections: innovations, challenges, and future directions","volume":"10","author":"Ni\u00f1o-Vega","year":"2024","journal-title":"J. Fungi"},{"key":"10.1016\/j.ejmech.2025.117801_bib134","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11908-022-00782-5","article-title":"Antifungal resistance and the role of new therapeutic agents","volume":"24","author":"Logan","year":"2022","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.ejmech.2025.117801_bib135","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s42770-023-00999-z","article-title":"Recent drug development and treatments for fungal infections","volume":"54","author":"Roy","year":"2023","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117801_bib136","article-title":"Fosmanogepix: the novel anti-fungal agent's comprehensive review of in vitro, in vivo, and current insights from advancing clinical trials","volume":"16","author":"Almajid","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2025.117801_bib137","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02215-22","article-title":"Antagonism of the azoles to olorofim and cross-resistance are governed by linked transcriptional networks in Aspergillus fumigatus","volume":"13","author":"Van Rhijn","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2025.117801_bib138","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/14728214.2022.2142207","article-title":"Existing and emerging therapies for the treatment of invasive candidiasis and candidemia","volume":"27","author":"De Bels","year":"2022","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.ejmech.2025.117801_bib139","article-title":"Update on therapeutic approaches for invasive fungal infections in adults","volume":"11","author":"Boutin","year":"2024","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117801_bib140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/17425247.2022.2084530","article-title":"Inhaled antifungal therapy: benefits, challenges, and clinical applications","volume":"19","author":"Ito","year":"2022","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.ejmech.2025.117801_bib141","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.3390\/molecules28227508","article-title":"Sulconazole-loaded solid lipid nanoparticles for enhanced antifungal activity: in vitro and in vivo approach","volume":"28","author":"Samee","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib142","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3390\/jpm12091540","article-title":"A meta-analysis on the effectiveness of sertaconazole 2% cream compared with other topical therapies for seborrheic dermatitis","volume":"12","author":"Georgescu","year":"2022","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.ejmech.2025.117801_bib143","doi-asserted-by":"crossref","DOI":"10.1080\/01443615.2023.2195001","article-title":"Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and clinical results. Review of the literature","volume":"43","author":"Regidor","year":"2023","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.ejmech.2025.117801_bib144","series-title":"Medicinal Chemistry and Drug Development","first-page":"449","article-title":"Triazole antifungal drug\u2014fluconazole","author":"Tu","year":"2025"},{"key":"10.1016\/j.ejmech.2025.117801_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2024.101473","article-title":"Itraconazole in human medicine and veterinary practice","author":"Sousa","year":"2024","journal-title":"J. Med. Mycol."},{"key":"10.1016\/j.ejmech.2025.117801_bib146","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/pharmaceutics15010266","article-title":"Nanotechnology-based approaches for voriconazole delivery applied to invasive fungal infections","volume":"15","author":"de Almeida Campos","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.117801_bib147","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14656566.2021.1996562","article-title":"Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections","volume":"23","author":"Panagopoulou","year":"2022","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117801_bib148","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1080\/14656566.2024.2416924","article-title":"Efinaconazole 10% solution: a comprehensive review of its use in the treatment of onychomycosis","volume":"25","author":"Gupta","year":"2024","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117801_bib149","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1080\/03639045.2021.2001485","article-title":"Development of bifunctional vaginal suppositories by joint use of terconazole and probiotic for treatment and prophylaxis of vulvovaginal candidiasis","volume":"47","author":"Pashayan","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejmech.2025.117801_bib150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5530\/ijper.55.1.28","article-title":"Appliance of the ICH Guidelines: forced degradation studies on abafungin and development of validated stability indicating method by 1st order derivative spectroscopy","volume":"55","author":"Pandey","year":"2021","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"10.1016\/j.ejmech.2025.117801_bib151","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections","volume":"10","author":"Cavassin","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.ejmech.2025.117801_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114969","article-title":"Reviving the interest in the versatile drug nystatin: a multitude of strategies to increase its potential as an effective and safe antifungal agent","volume":"199","author":"Sousa","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2025.117801_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106219","article-title":"Review of nanoformulations for treating ocular fungal infections","author":"Onugwu","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejmech.2025.117801_bib154","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/pharmaceutics16081065","article-title":"Polyene-based derivatives with antifungal activities","volume":"16","author":"Ngece","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.117801_bib155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/1574885517666220328141054","article-title":"A detailed insight onto the molecular and cellular mechanism of action of the antifungal drugs used in the treatment of superficial fungal infections","volume":"17","author":"Wal","year":"2022","journal-title":"Curr. Drug Ther."},{"key":"10.1016\/j.ejmech.2025.117801_bib156","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00403-025-04044-x","article-title":"A comprehensive evaluation of Naftifine's efficacy and safety in treating dermatophyte infections; systematic review and meta-analysis","volume":"317","author":"Abo Zeid","year":"2025","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.ejmech.2025.117801_bib157","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/membranes12121171","article-title":"Allylamines, benzylamines, and fungal cell permeability: a review of mechanistic effects and usefulness against fungal pathogens","volume":"12","author":"Hammoudi Halat","year":"2022","journal-title":"Membranes"},{"key":"10.1016\/j.ejmech.2025.117801_bib158","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","article-title":"Echinocandins\u2013structure, mechanism of action and use in antifungal therapy","volume":"37","author":"Szyma\u0144ski","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117801_bib159","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/jamp.2020.1645","article-title":"Pharmacokinetic and pharmacodynamic comparison of intravenous and inhaled caspofungin","volume":"34","author":"Yu","year":"2021","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejmech.2025.117801_bib160","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.3390\/molecules27207034","article-title":"Griseofulvin: an updated overview of old and current knowledge","volume":"27","author":"Aris","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117801_bib161","article-title":"Flucytosine and its clinical usage","volume":"10","author":"Sigera","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117801_bib162","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/10600280231195649","article-title":"Oteseconazole for the treatment of recurrent vulvovaginal candidiasis: a drug review","volume":"58","author":"Lanier","year":"2024","journal-title":"Ann. Pharmacother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:08:52Z","timestamp":1762265332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425005665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":162,"alternative-id":["S0223523425005665"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117801","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent research frontiers of heterocycles as antifungal Agents: Insights from the past five years","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117801"}}